Abstracts Traditional drug Lider-5 traditional medicine, rheumatism and arthritis disease which has been used experimental animals we created arthritis disease antioxidant system of the Lider-5 studied the impact of the loss. As a result of the research that you created via a test animal collagen II arthritis pathological articular tissues and blood plasma contained malondialidyegid In addition to reducing the antioxidant Glutathione is provided a system of the body, including supyeroksidismutaza enzymes to increase the amount of influence. As you can see in the traditional drug Lider-5 disorders antioxidant system, loss prevention, and treatment is effective, the effects of its ingredients contained Tinospora sinensis, Gentiana decumbens, such as antioxidant effect might be associated with key plant attendant substances.

Background. This study is to determine mode of metabolism on triple collaboration bridges of traditional medicine, modern medicine and NCM.Goal. To determine membrane redoxy potentials three line involves important regulation factors on mode of metabolism which relationship connected with rlung, mkris, and badgan symbolic code.Materials and Methods. Only 81 healthy individuals were involved in the study. Proton leak was determined by quantity rate of MDA in cell membrane and membrane resistance, proton conductance was determined by serum and urine oxidase activity.Results. The table 1 shows quantity rate of membrane resistance was decreased 1.08-1.52 fold, HDL content was decreased, and however LDL was increased. This result is to manifest low proton leak which means this type is likely belonged to badgan symbolic code with qualities cold fatty, earth, water. The table 2 shows serum and urine oxidize activity 2.22-6.1 fold was increased, HDL content was increased; UCP-3 gene activity relatively was increased. This result is to manifest highproton conductance which means this type is likely belonged to mkris symbolic code with qualities hot fatty, fire.Conclusions:1. Individuals with high proton leak and slow proton conductance had serum and urine oxidize activity were weak, therefore there are visceral and subcutaneous fat were low.2. Individuals with medium proton leak and high proton conductance had serum and urine oxidize activity were high, therefore there are visceral was low and subcutaneous fat was high.3. Individuals with weak proton leak and medium proton conductance had serum and urine oxidize activity were medium, therefore there are visceral was high and subcutaneous fat was low.

Glucose-6-phosphatase dehydrogenase (G6PD) deficiency is the most common enzyme deficiency in humans, affecting 400 million people worldwide and a high prevalence in persons of African, Middle Asian countries. The most common clinical manifestations are neonatal jaundice and acute hemolytic anemia, which is caused by the impairment of erythrocyte’s ability to remove harmful oxidative stress triggered by exogenous agents such as drugs, infection, or fava bean ingestion. Neonatal hyperbilirubinemia caused by glucose-6-phosphate dehydrogenase (G6PD) is strongly associated with mortality and long-term neurodevelopmental impairment. Aim:To determine a level of glucose-6-phosphate dehydrogenase in healthy neonates.The 76.5% of all participants (n=205) was assessed 4.36±1.15 Ug/Hb in normal reference range of G6PD other 23.5% (n=63) was 0.96±0.51 Ug/Hb with G6PD deficiency. In the both sex, 51.5% of male 0.88±0.46Ug/Hb (n=33) and 47.6%of female (n=30) 0.97±0.55Ug/Hb was assessed with G6PDdeficiency. Developing Jaundice period in number of 63 neonates with G6PD deficiency, 85.7% of neonates (n=54)was in 24-72 hours, 4% of neonates (n=3) was in 5-7 days and there is no sign of jaundice in 9% (n=6).Therefore neonates with G6PD deficiency, 53.9% (n=34)contiuned jaundice more than two weeks.G6PD deficiency was determined in male neonates (51.5%) more than female(47.6%). The 76.5% of all participants (n=205) was assessed 4.36±1.15 Ug/Hb in normal reference range of G6PD other 23.5% (n=63) of all participants was 0.96±0.51 Ug/Hb with G6PD deficiency. It shows that G6PD might be one potential risk of neonatal jaundice and hyperbilirubinemia in neonates in Mongolia.

Background : Diabetic ketoacidosis, an early and common complication at the initial diagnosis of Type 1 Diabetes Mel litus (T1DM), remains a significant clinical concern. The high prevalence of this complication in the pediatric population provided the rationale for conducting the present study. Aim: Our study aims to compare the incidence, clinical features, and physical measurements associated with diabetic ketoacidosis (DKA) at the time of initial diagnosis of Type 1 Diabetes Mellitus (T1DM), and to classify the severity of DKA based on selected laboratory findings. Materials and Methods: We conducted a retrospective observational study of newly diagnosed T1DM with DKA in children aged less than 18 years old at National Center for Maternal and Child Health during the period 2017-2022. The study compared the analysis of medical and laboratory records from patients medical charts. The severity of diabetic ketoacidosis (DKA) was classified based on laboratory criteria according to the 2022 guidelines of the International Society for Pediatric and Adolescent Diabetes (ISPAD). The study data were analyzed using STATA-16.0. Results: During the period from 2017 to 2022, a total of 124 children under 18 years of age (mean age: 9.11±3.84 years) were newly diagnosed with T1DM and included in the study, of whom 67.7% (n=84) presented with diabetic ketoacidosis (DKA). Of the children with DKA, 57.2% (n=48) had severe, 17.8% (n=15) had moderate, and 25.0% (n=21) had mild severity. Girls were more frequently affected (67.1%, n=47; p=0.871). Having a viral infection before the first diagnosis of type 1 diabetes (51.2%, n=43, p=0.011) and having high blood glucose levels at that time (25.8±9.32 mmol/l, p=0.012) were statistically significantly associated with diabetic ketoacidosis. The blood gas analysis of children with ketoacidosis showed pH 7.05±0.15, HCO3 8.68±4.27 mEq/l, and the group with severe ketoacidosis had higher blood potassium levels (4.08±0.8 mEq/l, 3.6±0.56 mEq/l, p=0.049) and blood glucose levels (28.37±9.23 mmol/L, 21.96±9.18 mmol/L, p=0.012) compared to the group with mild ketoacidosis. Conclusions 1. Diabetic ketoacidosis (DKA) was identified in 67.7% (n=84) of the children included in the study. 2. At the initial diagnosis of Type 1 Diabetes Mellitus (T1DM), vomiting and fatigue were the predominant clinical manifestations of DKA. 3. Severe DKA was observed in 57.1% (n=48) of the participants, with elevated serum potassium and glucose levels noted as contributing factors to the severity of ketoacidosis.

Considering the fact that it is becoming important to broaden the studies of herbal medicine with few side effects which can treat acute and chronic inflammations of the liver and biliary tract, liver cirrhosis and can prevent from transformation into cancer, we chose Saxifraga hirculus L as our study objective which has been used in liver and biliary disease treatments of Tibetan – Mongolian traditional medicine for many years. This study aims to study one of the species of the family Saxifrgaceaca, Saxifraga hirculus L’s liverprotective activity and effect on the liver and biliary tract diseases resulted from bile stasis, which frequently comes as an ingredient of compound prescription of the traditional medicine. 01/01 Study methods: Experimental pathological liver disease model was developed in total of 520 white rats and 80 white mice in 2 ways, Saxifraga hirculus L’s bile-forming and detoxifying function and effects on the detergent effect of bile, necrotic liver cell lysis and stability of lung cell surfactant were compared with the standard drugs such as Legalon and Cholasos and double proven by biochemical, pathohistologi and histochemical studies. 70% alcohol extract was prepared from the selected Saxifraga hirculus L, and dried and decocted extract was obtained from this and given to the experimental animals by oral intragastric tube in a dose of 100mg/kg. As the result of pathohistologi and histochemical study, necrosis and necrobiosis of liver cells were dominantly observed in CCl4 induced “toxic inflammation”, cholestatic syndrome and dysfunction of detoxication action were observed in Tetracycline Hydrochlorideinduced(druginduced)toxic inflammation in the experimental animals. The Saxifraga hirculus L’s most potent dose to treat and protect liver was estimated as 100mg/kg and this was 31 times lower than its LD50. In our study,Saxifraga hirculus L has possessed an anti-inflammatory effect on each stages of inflammation which is alteration, exudation and proliferation. In other hand, Saxifraga hirculus L increased the biliary secretion and excretion speed, protected from toxic detergent effect of bile acid, improved detoxication effect of the liver, protected from the necrotic cell lysis, showed an antioxidant and membrane stabilizing activity and these actions were compared with the standard medicines such as Legalon and Cholasos which in some cases, above mentioned effects were higher than these drugs. The hepatoprotective action of Saxifraga hirculus L may have been related to its contents such as compound flavonoids of the quercetin group, aglycone and bitter hyperoside. Also in the case of drug induced toxic hepatitis, Saxifraga hirculus L increased the amount of glycogen and nuclear DNA in the liver tissue by 22-24.5% compared to the control group and was proven by histochemical study.

Background: The immune response has become the basic use of today’s medical and biological sciences understanding, definition and realization when first introduced into the cognitive level with new theory of nine step closed cycle of protons related to membrane potentials three linear and s-NCM. Medicinal preparations for the immune system derived from traditional herbs have rarely been used therefore, we aim to determine the boost-reduction of immune response with preparation Antischemin with ingredients of Gingko biloba, Astragalus membranaceus and Scutellaria baicalensis. Materials and Methods: This study was carried out on the innovation-research bio-modeling laboratory of the “New Medicine Medical University”. Sheep blood was taken in heparin tube and centrifuged for 10min with speed of 2000rpm and plasma was isolated. Blood components were washed with physiological solution 3-4 times and 10% blood red cell suspension was prepared. Prepared 0.2ml of 10% sheep red cell suspension was injected to mice tail vein to create immune response model (N.K. Jerne and Nordin (1963)). IL-4 (pg), antibody titre SRBC-IgM(ng/mL), and hemagglutinin titre (%) was measured with ELISA kit and compared with control group. Comparing group animals used Salimon 1 ml/kg, Dexamethasone 1 mg/kg orally. The study was conducted in accordance with the approval of Ethics Review Committee of Ministry of Health (November 02, 2018 and approval number 10, №1). Result : In addition, comparing mice which used Antischemin 100 mg/kg orally with sheep blood injected group at day 5, IL-4 level increased by 12.11%, but conclution of antibodies against sheep blood-IgM concentration decreased by 28.7%, and hemagglutinin titre decreased by 27.5%, meaning we observed that the preparation can suppress immune response. Сonclusions Antischemin preparation meaning observed can suppress immune response.

Background: The correlation between hepatitis B, C viruses (HBV, HCV) and B cell non-Hodgkin’s Lymphoma (B-NHL) and reducing mortality have been studied extensively worldwide Objective: In this study, we aimed to determine the prevalence of HBsAg and anti-HCV positive cases among B-NHL patients and its influence on the survival rate of these patients (on ≤12 months). Materials and Methods: We have done a retrospective analysis on patients who aged over 20 years and newly diagnosed at the Hematology Center of the First State Hospital between 2015-2018. The patients’ information was collected according the study ethics. We divided the patients into 2 groups, survival rate less than 12 months (≤12 months) and survival rate more than 13 months (≥13 months), and compared them regarding age, gender, seroprevalence, and Ann-Arbor stage. Results: Overall, 226 patients (107 males and 119 females with average 54.4) were enrolled in the study. There were 15% HBsAg positive and 41,6% anti-HCV positive cases, while Baatarkhuu et al. (2005) reported (11.8%, 15.6%; p=0.160, p<0.00001) and Bekhbold et al. (2013) reported (11.1%, 10.6%; p=0.055, p<0.00001) in apparently healthy population. Moreover, anti-HCV positive cases among B-NHL patients were higher (p<0.00001) than those (27%) among hepatocellular carcinoma (HCC) patients and same (p=0.404) with those (39%) among liver cirrhosis patients in Mongolia (Bolormaa et al., 2009). Furthermore, 72.0% of all subjects in III-IV stages was accounted for HBsAg, anti-HCV positive group which had ≤12 months, while 52.1% of them was accounted for HBsAg, anti-HCV positive group which had ≥13 months and was statistical significantly lower (p=0.02). Conclusion Anti-HCV and HBsAg positive cases might contribute to survival rate with the B-NHL patients diagnosed at the III-IV stages. HCV prevalence among B-NHL subjects was significantly higher than that among the general population prevalence and was same with anti-HCV positive prevalence among the HCC.

Background: Chemotherapy-related acute exacerbation or hepatitis flares related to HCV positive B cell non-Hodgkin’s lymphoma (B-NHL) is one of the significant clinical issues Material and Method: We studied anti-HCV incidences among patients newly diagnosed with B-NHL, from 2015 to 2018. Survey data were collecting from medical history, electronic medical record system of First Central Hospital was acquired and collected according to the research ethics (approved by Ethics Committee of Ministry of Health, No.4 on June 19, 2017). Also, cases of chemotherapy-related acute exacerbation (AE) for HCV-RNA positive cases were studied. Student’s t-test or nonparametric statistics were utilized to test for statistically significant differences in continuous variables, whereas the chi-square or Fisher’s exact test was used for categorical variables. p<0.05 was considered statistically significant. Results: The study showed that 39.5% of 233 cases with B-NHL are anti-HCV positive. Anti-HCV positive prevalence among B-NHL subjects was significantly higher compared to the general population. Chemotherapy-related AE occurred in 21.05% for the anti-HCV positive group and 36.36% for HCV-RNA positive group. Furthermore, before chemotherapy alanine aminotransferase (ALT) median was 15.2 for the group without AE, whereas it was 48.2 for the group with AE (p<0.01). Conclusions Our study showed that the prevalence of anti-HCV positive among B-NHL patients was significantly higher than the general population prevalence. For all cases of AE, HCV-RNA was positive, and these patients were treated with only chemotherapy without any anti-viral treatment. Anti-viral therapy needs to be introduced urgently to prevent AE since liver fibrosis is aggravated quickly after AE.

Introduction: Rhodiola rosea L. (R.rosea) is a popular plant in traditional medicine of the Nordic countries, Eastern Europe, and Asia. R.rosea plants are successfully cultivated in Mongolia. The Botanical Garden of Medicinal Plants under the “Monos” Group started to cultivate R. rosea since May 2015. Objective: The aim of this research was to study the salidroside contents of R.rosea collected from Zavkhan and Khuvsgul province, Mongolia, and cultivated in the Botanical Garden of Medicinal Plants, Drug research Institute, Monos group. Material and Methods: The underground parts of wild roseroot plants were collected from April to May 2020 from Jargalant soum, Khuvsgul province, and Nomrog soum, Zavkhan province, 3-years and 4-years-old cultivated R.rosea gathered from the Botanical Garden of Medicinal Plants in April 2020. For comparison, 4-year-old Rhodiola grenulata (R. grenulata) was ordered from Shanxi Zhendong Genuine Medicinal Materials Development Co., Ltd, China, and used for the study. The quantity of the salidroside constituents of the underground parts were compared and the sourcing of roseroot raw material was evaluated. Chemical analysis of roots and rhizome of R. Rosea namely the appearance, identification, moisture, organic impurities, mineral impurities, residue on ignition, water-soluble extractives, fresh weight of roots, and salidroside content were determined according to the National Pharmacopoeia of Mongolia (NPhM) 2011. Microbiological analysis was performed in accordance with the requirements of grade 3b specified in Annex 1 of the Order No. A / 219 of the Minister of Health dated May 30, 2017 to determine the degree of microbiological purity in medicinal products of roots and rhizome raw materials. Result: The content of salidroside, the main biologically active substance of R.rosea plant, was 1.57% in samples collected from Zavkhan province, 1.45% in samples collected from Khuvsgul province, 1.7% in samples grown in China and 0.25% for 3-years-old samples and 1.89% for 4-years-old samples grown in the Botanical Garden of Medicinal Plants, Monos group, Mongolia. In addition, these raw materials meet the general requirements for plant raw materials and microbiological parameters. Conclusion Samples of underground parts of R.rosea cultivated for 4 years in the Botanical Garden of Medicinal Plants have the highest content (1.89%) of the salidrosde. Therefore, it is suggested that the roots and rhizomes of R.rosea planted in the future can be standardized and used as a raw materials for medicines.

Background: Gout is a chronic inflammatory disorder stemming from metabolic dysfunction, characterized by the accumulation of monosodium urate crystals in joints and soft tissues due to prolonged hyperuricemia. Clinically, it often manifests with abrupt onset of intense joint pain, erythema, swelling, and tenderness, particularly in the small joints of the lower extremities such as the first metatarsophalangeal joint, ankles, and knees. In its chronic form, gout can lead to the development of tophi—firm nodular deposits of urate crystals— resulting in joint deformities, limited mobility, and systemic complications affecting the renal and cardiovascular systems. This case report describes the integrative management of a 68-year-old male patient with a long-standing history of chronic tophaceous gout, presenting with acute exacerbation involving multiple joints and extensive tophaceous deposits. The patient underwent a course of traditional Mongolian medical treatment, incorporating bloodletting therapy (hanuur), soaking therapy (devteeleg zasal), and phytotherapeutic remedies. Conclusion The treatment yielded notable clinical improvements: cupping therapy facilitated the reduction of joint inflammation and edema, alleviated pain, and enhanced peripheral circulation during the acute phase. Soaking therapy using medicated decoctions was effective in softening and reducing the size of tophi, promoting wound drying, restoring joint mobility, and improving overall functional capacity. The patient reported a marked enhancement in quality of life following the integrative treatment course. This case highlights the potential of traditional Mongolian medical interventions as adjunctive or alternative therapeutic strategies for managing severe gout, particularly in cases refractory to conventional pharmacological treatment. Further clinical research and controlled studies are warranted to validate these findings and to explore the broader application of traditional therapies in gout management.